Kalbe Farma Tbk vs Tripar Multivision Plus Tbk. — how do they compare? Kalbe Farma Tbk trades at Rp720 (market cap 33T, 98.44M 24h volume), while Tripar Multivision Plus Tbk. trades at Rp206 (market cap 1.36T, 1.13M 24h volume). The key difference: Kalbe Farma Tbk is far larger — about 24.3× Tripar Multivision Plus Tbk.'s market cap, and Kalbe Farma Tbk is more actively traded (98.44M versus 1.13M). Which is the better fit depends on your goals.
| KLBF | RAAM | |
|---|---|---|
Market Cap | 33T | 1.36T |
Volume | 98.44M | 1.13M |
Lot | 984.38K | 11.26K |
Turnover | 70.64B | 231.39M |
Average Price | 717.58 | 205.46 |
Value | 70.64B | 231.39M |
Indicative Equilibrium Price | 720 | 206 |
Indicative Equilibrium Volume | 43.62K | 173 |
Trailing returns across standard periods
Latest headlines on both assets
PT Kalbe Farma Tbk (the Company) was established in the Republic of Indonesia, within the framework of the Domestic Capital Investment Law No. 6 Year 1968, as amended by Law No. 12 Year 1970, basedon Notarial Deed No. 3 of Raden Imam Soesetyo Prawirokoesoemo datedon September 10th, 1966. The Company, which started commercial operation in 1966.
Read more on KLBF →PT Tripar Multivision Plus Tbk (“the Company”) was establishedbased on Deed of Establishment of Limited Liability Company No. 17 dated 6 December 1990 drawn up before Adlan Yulizar, S.H., notary in Jakarta.
Read more on RAAM →